Toggle light / dark theme

“The world’s first purchase agreement for net-zero carbon supersonic aircraft marks a significant step toward our mission to create a more accessible world,” said Boom CEO Blake Scholl in a statement.

The planes, which will fly twice the speed of current passenger jets, are expected to be rolled out in 2025, take flight in 2026, and start carrying passengers in 2029.

Since Denver-based Boom was founded in 2014 it has raised $270m in capital and now has 150 employees.

The space agency is launching two missions to study Venus’ atmosphere and geological history.


“I did a lot of screaming and jumping up and down,” Grinspoon tells Inverse. “I scared my dog.”

On Wednesday, NASA selected both DAVINCI+ and another Venus mission, VERITAS, to study the planet’s atmosphere and geological history. It will mark a return to Venus after decades away.

By returning to Venus, it could answer questions both intriguing, like if Venus ever had the right conditions for life, and existential, like if Venus is a vision of our future.

## JOURNAL OF THE AMERICAN CHEMICAL SOCIETY • JUN 4, 2021.

# *A lovely single step bio-inspired process with some interesting complex benefits particularly for humans on Mars.*

*by holly ober, university of california — riverside*

A team led by UC Riverside engineers has developed a catalyst to remove a dangerous chemical from water on Earth that could also make Martian soil safer for agriculture and help produce oxygen for human Mars explorers.

Perchlorate, a negative ion consisting of one chlorine atom bonded to four oxygen atoms, occurs naturally in some soils on Earth, and is especially abundant in Martian soil. As a powerful oxidizer, perchlorate is also manufactured and used in solid rocket fuel, fireworks, munitions, airbag initiators for vehicles, matches and signal flares. It is a byproduct in some disinfectants and herbicides.

Because of its ubiquity in both soil and industrial goods, perchlorate is a common water contaminant that causes certain thyroid disorders. Perchlorate bioaccumulates in plant tissues and a large amount of perchlorate found in Martian soil could make food grown there unsafe to eat, limiting the potential for human settlements on Mars. Perchlorate in Martian dust could also be hazardous to explorers. Current methods of removing perchlorate from water require either harsh conditions or a multistep enzymatic process to lower the oxidation state of the chlorine element into the harmless chloride ion.

Doctoral student Changxu Ren and Jinyong Liu, an assistant professor of chemical and environmental engineering at UC Riverside’s Marlan and Rosemary Bourns College of Engineering, took inspiration from nature to reduce perchlorate in water at ambient pressure and temperature in one simple step.

Banner Smoked Fish Inc. is recalling 43 of its s moked fish products in all package sizes, all package types and all lots, because of a potential Listeria monocytogenes contamination.

The problem was discovered through FDA routine inspection, and the products were found to be processed under unsanitary condition.

The recalled smoked fish were distributed through retail stores and also online in the New York, New Jersey, Illinois, Pennsylvania, California, Florida, Nebraska, Arizona, Massachusetts, Maryland, Virginia, Nevada, Oregon, Wisconsin, North Carolina, South Carolina and Georgia.

Antivirus software company Norton has released a new crypto product that allows users to mine ether (ETH) from their personal computers.


NortonLifeLock, formerly Symantec Corporation, has released a new crypto product that allows users to mine ether (ETH) from their personal computers.

The product, Norton Crypto, is currently available to select customers who use the company’s antivirus software called Norton 360. The public launch of the product is expected “in the coming weeks.

How does the product work? A crypto-mining software is installed within Norton 360, which allows users to run it when their computers are idle.

Enrolling Tens Of Thousands Of Dogs, In 10-Year Study, To Unlock Healthy Aging Secrets — Dr Matt Kaeberlein, Founder / Co-Director, The Dog Aging Project, Professor, University of Washington, joins me on Progress, Potential, And Possibilities Nathan Shock Centers #Rapamycin #Dogs #Aging #Longevity #Healthspan #Geroscience.

#MitochondrialDisease


Dr. Matt Kaeberlein is Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences, at the University of Washington.

Dr. Kaeberlein received his PhD from MIT in Biology, did his post-doc in the Department of Genome Sciences, University of Washington, and his research interests are focused on basic mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life.

Dr. Kaeberlein has published nearly 200 papers in top scientific journals and has been recognized by several prestigious awards, including a Breakthroughs in Gerontology Award, an Alzheimer’s Association Young Investigator Award, an Ellison Medical Foundation New Scholar in Aging Award, a Murdock Trust Award, a Pioneer in Aging Award, and the Vincent Cristofalo Rising Star in Aging Research.

The latest from Calico. A bit technical.


Reprogramming of ordinary somatic cells into induced pluripotent stem cells (iPSCs) was initially thought to be a way to obtain all of the patient matched cells needed for tissue engineering or cell therapies. A great deal of work has gone towards realizing that goal over the past fifteen years or so; the research community isn’t there yet, but meaningful progress has taken place. Of late, another line of work has emerged, in that it might be possible to use partial reprogramming as a basis for therapy, delivering reprogramming factors into animals and humans in order to improve tissue function, without turning large numbers of somatic cells into iPSCs and thus risking cancer or loss of tissue structure and function.

Reprogramming triggers some of the same mechanisms of rejuvenation that operate in the developing embryo, removing epigenetic marks characteristic of aged tissues, and restoring youthful mitochondrial function. It cannot do much for forms of damage such as mutations to nuclear DNA or buildup of resilient metabolic waste, but the present feeling is there is nonetheless enough of a potential benefit to make it worth developing this approach to treatments for aging. Some groups have shown that partial reprogramming — via transient expression of reprogramming factors — can reverse functional losses in cells from aged tissues without making those cells lose their differentiated type. But this is a complicated business. Tissues are made up of many cell types, all of which can need subtly different approaches to safe reprogramming.

Today’s open access preprint is illustrative of the amount of work that lies ahead when it comes to the exploration of in vivo reprogramming. Different cell types behave quite differently, will require different recipes and approaches to reprogramming, different times of exposure, and so forth. It makes it very hard to envisage a near term therapy that operates much like present day gene therapies, meaning one vector and one cargo, as most tissues are comprised of many different cell types all mixed in together. On the other hand, the evidence to date, including that in the paper here, suggests that there are ways to create the desired rejuvenation of epigenetic patterns and mitochondrial function without the risk of somatic cells dedifferentiating into stem cells.